Physician

Aaron Newey Weaver, M.D.

According to 2025 Medicare claims, Aaron Weaver, M.D. (NPI: 1750594222) practices interventional cardiology in the Provo-Orem-Lehi, UT market, with the plurality of this provider's patient population coming from Utah, UT. This provider's primary affiliated billing organization is REVERE HEALTH PC (NPI: 1093764805; TIN: 870281028) and primary practice location at 84604-3305. Weaver is affiliated with the Revere Health Collaborative Network, LLC (ACO ID: D0042), participating under the REACH model.

Weaver's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,588 traditional Medicare patients, billed 5,990 HCPCS/CPT codes, and received $512,478 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 11,013 prescription claims across 1,363 beneficiaries totaling $2,143,303 in drug costs, led by Eliquis (Apixaban). DME data shows 72 claims. Open Payments data shows 107 records totaling $1,731. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $349,949 to $512,478. Similarly, Part D prescription costs have moved sharply higher in recent years, from $552,862 to $2,143,303. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $45,899 to $3,037.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,205	6,861	$349,949
2016	2,142	6,390	$318,762
2017	1,938	6,273	$325,623
2018	1,754	5,215	$253,375
2019	1,977	5,779	$297,282
2020	1,619	5,269	$311,850
2021	1,453	5,400	$443,708
2022	1,458	5,426	$400,118
2023	1,717	5,539	$429,791
2024	1,588	5,990	$512,478

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	821	6,931	$552,862
2016	888	7,891	$750,312
2017	903	7,457	$994,712
2018	942	7,381	$968,554
2019	958	7,030	$1,009,656
2020	1,029	7,742	$1,125,555
2021	1,094	8,226	$2,174,783
2022	1,126	8,180	$2,170,745
2023	1,239	8,804	$2,028,713
2024	1,363	11,013	$2,143,303

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	45	365	$43,214
2016	33	313	$22,218
2017	23	223	$10,344
2018	19	140	$6,413
2019	N/R	58	$3,442
2020	N/R	39	$2,631
2021	N/R	95	$6,244
2022	N/R	97	$5,639
2023	N/R	76	$4,729
2024	N/R	72	$3,037

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	603	618	$88
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	610	843	$82
80061	Blood test, lipids (cholesterol and triglycerides)	373	477	$13
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	454	574	$12
93018	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician	179	180	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	681	37,514	$716,088
Opsumit	Macitentan	34	1,020	$431,936
Xarelto	Rivaroxaban	114	7,404	$135,102
Entresto	Sacubitril/Valsartan	134	7,041	$125,655
Jardiance	Empagliflozin	128	6,417	$123,332

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	36	$2,476
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	36	$561

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	107	$1,731	Merck Sharp & Dohme LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aaron Newey Weaver, M.D.?

Tedicare shows public-source Medicare data for Aaron Newey Weaver, M.D. (NPI 1750594222), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aaron Newey Weaver, M.D. have ACO affiliation data?

Aaron Newey Weaver, M.D. is shown with ACO affiliation data for Revere Health Collaborative Network, LLC (REACH, ACO ID D0042).

What billing organization is linked to Aaron Newey Weaver, M.D.?

Aaron Newey Weaver, M.D. is linked to REVERE HEALTH PC (billing NPI 1093764805) in the available physician profile data.

Does Aaron Newey Weaver, M.D. have Open Payments data?

Aaron Newey Weaver, M.D. has 107 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.